E3 Breast Cancer Taxotere Combination
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Vandetanib (ZD6474)|DRUG: Docetaxel
Sponsor: Genzyme, a Sanofi Company